SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Chun‐Kit Yuen(University of Hong Kong), Kin‐Hang Kok(University of Hong Kong), Wan‐Man Wong(University of Hong Kong), Joy-Yan Lam, Dong‐Yan Jin(University of Hong Kong), Hin Chu(HKU-Pasteur Research Pole), Jasper Fuk‐Woo Chan(Hong Kong Baptist University), Jian‐Piao Cai(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Long‐Fung Mak(University of Hong Kong), Xiaohui Wang(Capital University), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation)
Cited by 10
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k